Today, we confront emerging threats from a range of respiratory viruses, insect-transmitted viruses, and viruses we have not ...

Kotsopoulos noted that BRCA carriers have a substantially increased lifetime risk of breast and ovarian cancer. Management of ...

True or False: A large observational study found that adults with diabetes who used GLP-1 receptor agonists had more ...

Helen Tager-Flusberg, PhD, director of the Center for Autism Research Excellence at Boston University, said Johnson has ...

Use of the dual GIP/GLP-1 drug tirzepatide (Mounjaro, Zepbound) was associated with a significantly reduced risk of glaucoma ...

The final Dec. 5 memo, according to FDA employees with knowledge of the situation, states that under an established World ...

In May 2018, andexanet was granted accelerated approval as the sole antidote on the market for the DOACs rivaroxaban (Xarelto ...

GLP-1 receptor agonists were tied to a 16% lower risk of epilepsy in adults with type 2 diabetes. Epilepsy is an ...

This is worrisome if Fulnecky plans to enter medicine. Past behavior predicts future behavior, and rewarding bad behavior reinforces it. Bottom line: we should neither reward low-quality work in ...

Sources tell CNN the FDA is planning to slap a black boxed warning on COVID vaccines -- the agency's most serious warning ...

Taking care of your emotional and psychological health is an important part of your treatment and the key to maintaining a ...